Navigation Links
VG Energy's Lipid Enhancement Technology Independently Confirmed in First Phase of Testing for Potential Commercial Production of Biofuels
Date:6/8/2011

SAN MARINO, Calif., June 8, 2011 /PRNewswire/ -- VG Energy, Inc., a majority-owned subsidiary of Viral Genetics, Inc. (Pinksheets: VRAL), has received independent confirmation from BioProcess Algae, LLC of early laboratory studies that verify an increase in yields of algae oils following treatment with VG Energy's Metabolic Disruption Technology (MDT) additives. These test studies hold promise for the use of VG's proprietary technology in the large-scale commercial production of biofuels as well as high-value oils used in cosmetics, food and nutraceuticals, among other products.

"We are pleased but not surprised by these early results," said Viral Genetics CEO Haig Keledjian. "Seeing these positive results has been the confirmation that was needed to go forward with the next phase of this particular study."

The results represent the completion of the first two steps of a viability study that VG Energy retained BioProcess Algae to conduct, originally announced on March 25, 2011. BioProcess Algae initially performed a Feasibility Assessment Study to establish baseline performance of VG's technology, with algal strains provided by VG and additional strains from BioProcess Algae. Recognizing an increase in Mean Nile Red Fluorescence, with the strongest effects seen after 48 hours, the study verifies bench-level results of VG's lipid enhancement technology. The next step will be a Dosage Response Study followed by testing at industrial-scale studies.

The Dosage Response Study, expected to be completed within a month, will determine the optimal dosage for the highest lipid outcome in the plant strains selected, according to Dr. M. Karen Newell Rogers, VG Energy's head of scientific research. "It is important that we are thorough in our studies, dosage and selection in order to continuously move the bar to get the highest yields possible," noted Dr. Newell Rogers.

"Although we've seen these results now internally multiple times, it was impor
'/>"/>

SOURCE VG Energy, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Peregrine Pharmaceuticals Awarded New U.S. Patent Further Strengthening Its Anti-Phospholipid Patent Portfolio
2. Atherotech Taps Canyons Medical Center Director, Lipidologist as Chief Medical Officer
3. Merck/Schering-Ploughs Zetia and Vytorin Have Lost Substantial Patient Share in Second- and Third-Line Therapy Since Last Years Analysis of Dyslipidemia
4. Atherotechs Advanced Lipid Profile Featured in Lipoprotein and Epidemiology Research at ACC 2010
5. ACCORD Lipid Study Brings new Hope to People With Type 2 Diabetes and Atherogenic Dyslipidemia Says International Academic Foundation
6. Atherotech Emphasizes Predictive Value of VAP(R) Cholesterol Test at National Lipid Association Meeting
7. Expanded Lipoprotein Testing, VAP® Cholesterol Test Discussed at National Lipid Association Summer Clinical Lipid Update
8. Liquid crystal droplets discovered to be exquisitely sensitive to an important bacterial lipid
9. Varian to Showcase RapidArc(TM) Radiotherapy Technology Enhancements at ASTRO 2008
10. Frost & Sullivan Recognizes Martek Biosciences for Unique and Customer-Focused Strategies With Customer Value Enhancement Award
11. HOGGAN Ergo Announces Highly Anticipated Enhancements to the ergoFET Handheld Digital Force Gauge, Greatly Impacting the Field of Ergonomic Research and Application
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... OXFORD, England , May 22, 2013 ... inhaled, novel drug-only formulation of glycopyrronium bromide designed using ... speciality pharmaceutical company developing a portfolio of inhaled ... 2 clinical study with PSX1002 that will assess its ... range of doses in patients with moderate to severe ...
(Date:5/21/2013)...  The Lindsley F. Kimball Research Institute of the New ... Grand Challenges Explorations winner, an initiative funded by the ... Sara Lustigman , Head of the Laboratory of Molecular ... project, titled Innovative 3-D in vitro culturing ... screen drugs to help eliminate onchocerciasis (river blindness) in ...
(Date:5/21/2013)... Through science fairs, workshops, kits for building ... 25 organizations will continue their work to increase awareness ... in daily life with the aid of SPIE ... 10 countries, are the first of two groups of ... the international society for optics and photonics , in ...
(Date:5/21/2013)... 2013 Alpha Source, Inc., a ... be exhibiting for the 13th consecutive year at ... (AAMI) 2013 Conference and Expo. The conference brings ... manufacture healthcare technologies. This year’s event will be ... , The three-day event draws over 1,500 ...
Breaking Biology Technology:Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 2Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 3Prosonix Initiates Phase 2 Clinical Study with PSX1002 in Patients with Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) 4New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 2New York Blood Center's Research Institute Receives Grand Challenges Explorations Grant For Groundbreaking Research in Global Health and Development 3Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 2Learning About Light: Education Outreach Projects Funded in 10 Countries Through First Round of SPIE Grants 3Alpha Source, Inc. to Exhibit at the AAMI 2013 Conference and Expo 2
... CryoLife, Inc. (NYSE: CRY ), ... today that it will participate in the Sidoti & Company, ... The Grand Hyatt Hotel on Wednesday, March 25, 2009.D. Ashley ... officer of CryoLife, Inc., will present a corporate overview at ...
... CARMEL, Israel, March 19 InSightec Ltd. reported,today that it ... its existing investors. , Elbit Imaging ... on March,18, 2009. Additional US$7.5M would be invested no later ... , The investment will take the ...
... Inc. (Nasdaq: NLTX ), a leading company ... patients, today announced that, pursuant to Nasdaq Marketplace Rule ... ended December 31, 2008, included in the Company,s Annual ... contained a going concern qualification from its independent registered ...
Cached Biology Technology:CryoLife to Present at Sidoti's 13th Annual New York Emerging Growth Institutional Forum 2InSightec Ltd. Announces US$15 Million Investment Round 2InSightec Ltd. Announces US$15 Million Investment Round 3Nile Therapeutics Announces Information in Compliance With NASDAQ Marketplace Rule 4350 and Reiterates 2009 Objectives 2Nile Therapeutics Announces Information in Compliance With NASDAQ Marketplace Rule 4350 and Reiterates 2009 Objectives 3
(Date:5/22/2013)... important new details on how climate change will affect ... in the Journal of Animal Ecology . This ... and informing policymakers of how species are likely to ... is a growing recognition among biologists that climate change ... that this is going to have very important consequences ...
(Date:5/22/2013)... May 22, 2013. Plastic additives known as phthalates ... everywhere: They turn up in flooring, plastic cups, ... the Centers for Disease Control and Preventionthe bodies ... have come under increasing scrutiny. A growing collection ... can leech from packaging and mix with food) ...
(Date:5/21/2013)... "place" is increasingly being considered in the management ... new resource that can help them recognize and ... places in their lives. , Place-Based Conservation: ... co-edited by the Pacific Northwest Research Station,s Linda ... to conservation. The book is published by Springer ...
Breaking Biology News(10 mins):UCLA life scientists present new insights on climate change and species interactions 2UCLA life scientists present new insights on climate change and species interactions 3UCLA life scientists present new insights on climate change and species interactions 4UCLA life scientists present new insights on climate change and species interactions 5Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2
... in biomedical science are on the horizon with ... Infrastructure (Instruct) in support of European biomedical research. ... (ESFRI) is involved in establishing about 40 such ... is one such biomedical project, whose aim is ...
... center responsible for responding goes into gear, setting off a ... from the adrenal glands. Dr. Gil Levkowitz ... now revealed a new kind of ON-OFF switch in the ... from the brain that stimulates cortisol release in the body. ...
... by a University of California, Davis, plant scientist delivers a ... world-renowned wine industry. The study is set for publication ... the Proceedings of the National Academy of Sciences. "Many ... plant, but we believe that most microbes would have difficulty ...
Cached Biology News:European Integrated Structural Biology Infrastructure launching 2A unique on-off switch for hormone production 2Fused genes tackle deadly Pierce's disease in grapevines 2
... Zyagen tissue microarrays are derived from ... to rigorous quality control procedures to ensure ... are manually assembled in one block, sectioned ... mounted on coated slides. Sections are large ...
... Zyagen tissue microarrays are derived from ... to rigorous quality control procedures to ensure ... are manually assembled in one block, sectioned ... on coated slides. Sections are large (3-5mm ...
... from frozen embedded tissue blocks, which are ... ensure the highest quality. Tissues of each ... sectioned at a thickness of 7microns and ... (3-5mm in diameter) in comparison to core ...
... are derived from frozen embedded tissue blocks, ... procedures to ensure the highest quality. Tissues ... one block, sectioned at a thickness of ... are large (3-5mm in diameter) in comparison ...
Biology Products: